Corey M. McCann, MD, PhD, is the President and CEO of Pear Therapeutics, a pioneer in prescription digital therapeutics, as the first company to receive market authorization for software to treat disease. Previously, Corey was an investor with MPM Capital, where he evaluated new healthcare investment opportunities, managed relationships with strategic partners, and oversaw strategy and execution at portfolio companies. Prior to MPM, he was an Engagement Manager with McKinsey & Company, where he advised pharmaceutical, medical device, and biotechnology companies on the acquisition, development, and comme...read more